Reset

Advanced Filters
Friday
02:15pm - 03:45pm EDT - September 21, 2018 | Room: Rhythms Ballroom II-III
Credits Available:
1.50 CH | 1.50 Rx

This workshop provides an overview of considerations for practitioners when prescribing medications for patients with chronic kidney disease (CKD). Infection treatment agents, pain relievers, biologic mediators, and anticoagulants and the potential effects on kidney function in CKD patients are addressed.

Continuing Education Instructions and Disclosure Information


Contact hours available until 9/24/2020.


Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: Elizabeth St. John – Employee, Fresenius Kidney Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Learning Outcome:

APNs will state an increased ability to utilize biologic mediators when prescribing and utilizing biologic mediators.


Sunday
08:30am - 09:45am EDT - September 23, 2018 | Room: Napoleon Ballroom A1-B3
Credits Available:
1.25 CH | 1.25 Rx

Continuing Education Instructions and Disclosure Information

Contact hours available until 9/24/2020.


Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures: Elizabeth St. John – Employee, Fresenius Kidney Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
Supported by an educational grant from AstraZeneca

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Learning Outcomes:

Advanced practice nephrology nurses will describe an increased confidence in prescribing and evaluating the effectiveness of medications used for the treatment of hyperkalemia in their patients.

Nephrology nurses will relate the assessments of patients requiring pharmaceutical treatment for hyperkalemia to include the desired outcome, the potential side effects, and the education to be provided to patients.